Cellectis SA (NASDAQ:CLLS)
| 1.72 Delayed Data As of Sep 22 |  +0.05 / +2.99%Today’s Change | 1.58 Today|||52-Week Range 4.04 | -18.10% Year-to-Date |
Latest CLLS News | Press Releases
No recent news for Cellectis SA.
Today’s Trading
| Previous close | 1.67 |
| Today’s open | 1.65 |
| Day’s range | 1.65 - 1.73 |
| Volume | 1,095 |
| Average volume (3 months) | 47,891 |
| Market cap | $95.6M |
Data as of 3:59pm ET, 09/22/2023
Growth & Valuation
| Earnings growth (last year) | +8.54% |
| Earnings growth (this year) | +23.29% |
| Earnings growth (next 5 years) | +1.50% |
| Revenue growth (last year) | -66.54% |
| P/E ratio | NM |
| Price/Sales | 4.99 |
| Price/Book | 0.67 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AQSTAquestive Therapeuti... | -0.06 | -3.68% |
| ABEOAbeona Therapeutics ... | +0.21 | +5.82% |
| CMRXChimerix Inc | -0.01 | -1.44% |
| ACHVAchieve Life Science... | -0.04 | -0.91% |
Data as of 3:59pm ET, 09/22/2023
Financials
| Next reporting date | November 9, 2023 |
| EPS forecast (this quarter) | -$0.38 |
| Annual revenue (last year) | $19.2M |
| Annual profit (last year) | -$106.1M |
| Net profit margin | -473.60% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Paris, Ile-de-france |
Forecasts
